Known targets — ChEMBL curated mechanism
ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4
The experimentally established mechanism targets of Alpha-Tocopherol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.86 |
| ▸ | TTPA | P49638 | 3/20 | 0.86 |
| ▸ | MAPT | P10636 | 2/20 | 0.86 |
| ▸ | MEN1 | O00255 | 2/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.86 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.86 |
| ▸ | USP2 | O75604 | 1/20 | 0.86 |
| ▸ | THRB | P10828 | 1/20 | 0.86 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.86 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.78 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.78 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.76 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.76 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.71 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.67 |
| ▸ | AKT1 | P31749 | 2/20 | 0.51 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.51 |
| ▸ | PHLPP1 | O60346 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Tocopherol SCHEMBL27995975 | 1.00 | LMNA (0.86) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL28110607 | 0.98 | LMNA (0.82) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL4556023 | 0.98 | LMNA (0.82) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL27991376 | 0.97 | LMNA (0.81) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL360251 | 0.97 | LMNA (0.84) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL28434587 | 0.97 | LMNA (0.84) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL3950296 | 0.97 | LMNA (0.84) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL27697040 | 0.97 | LMNA (0.84) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL358455 | 0.96 | LMNA (0.82) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL28838443 | 0.96 | LMNA (0.82) | LMNATTPAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7484 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075463-A | Pharmaceutical composition containing melagatran besylate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12564552-B2 | Oral product with a basic amine and an ion pairing agent | Nicoventures Trading Limited (GB) | 2026-03-03 | — | — | US | claimed |
| EP-4687502-A1 | STARCHLESS MOLDING PROCESS FOR ORAL PRODUCTS | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | claimed |
| EP-4687504-A1 | ORAL COMPOSITIONS AND METHODS OF MANUFACTURE | Nicoventures Trading Limited (GB) | 2026-02-11 | — | — | EP | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| US-12527803-B2 | Testosterone dodecanoate compositions and methods | LIPOCINE, INC. | 2026-01-20 | — | — | US | claimed |
| US-12453713-B2 | Liquid formulation to treat a corneal tissue | VISION ENGINEERING ITALY SRL (IT) | 2025-10-28 | — | — | US | claimed |
| EP-4628583-A1 | BICYCLIC ABASIC NUCLEIC ACID ANALOGS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM | Shanghai Argo Biopharmaceutical Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| US-20250268969-A1 | OPHTHALMIC COMPOSITION | Iromed Group S.r.l. (IT) | 2025-08-28 | — | — | US | claimed |
| WO-1994020072-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | PHARMACIA AB (SE) | 1994-09-15 | — | — | WO | claimed |
| WO-1993003720-A2 | METHODS AND COMPOSITIONS FOR TREATING SUNBURNS | TREVITHICK JOHN R (CA) | 1993-03-04 | — | — | WO | claimed |
| US-5114957-A | Tocopherol-based antiviral agents and method of using same | BIODOR U.S. HOLDING (US) | 1992-05-19 | — | — | US | claimed |
| US-4873088-A | ADRIAMYCIN AND A SECONDARY COMPOUND TO ENHANCE ITS EFFECTIVENESS AND REDUCING TOXICITY; ENTRAPPED IN LIPOSOMES | LIPOSOME TECHNOLOGY, INC. (US) | 1989-10-10 | — | — | US | claimed |
| US-4870196-A | MELTING WITH WAX, SPRAYING IN PRESENCE OF POWDER, FLUIDIZATION WITH AIR | DANOCHEMO A/S (DK) | 1989-09-26 | — | — | US | claimed |
| WO-1988000045-A1 | METHOD OF PREPARING POWDERED, FREE-FLOWING TOCOPHERYL SUCCINATE | DANOCHEMO A/S (DK) | 1988-01-14 | — | — | WO | claimed |
| EP-0171009-A2 | Purification of tocopherols by extraction | HENKEL CORPORATION (a Delaware corp.) (US) | 1986-02-12 | — | — | EP | claimed |
| EP-0153955-A1 | LIPOSOME DELIVERY METHOD FOR DECREASING THE TOXICITY OF AN ANTITUMOR DRUG | HEALTH RESEARCH, INC. (US) | 1985-09-11 | — | — | EP | claimed |
| WO-1985000968-A1 | LIPOSOME DELIVERY METHOD FOR DECREASING THE TOXICITY OF AN ANTITUMOR DRUG | HEALTH RESEARCH, INC. (US) | 1985-03-14 | — | — | WO | claimed |
| US-4269835-A | Nasal composition for relieving nasal distress | WHITTLE BARRY J | 1981-05-26 | — | — | US | claimed |